Page last updated: 2024-08-22

actinium and Neoplasms

actinium has been researched along with Neoplasms in 28 studies

Research

Studies (28)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.57)18.2507
2000's8 (28.57)29.6817
2010's17 (60.71)24.3611
2020's2 (7.14)2.80

Authors

AuthorsStudies
Bruchertseifer, F; Caveliers, V; Covens, P; D'Huyvetter, M; Dekempeneer, Y; Lahoutte, T; Miller, BW; Morgenstern, A; Pruszyński, M; Rodak, M; Sevenois, MB; Wojewódzka, M1
Bruchertseifer, F; Morgenstern, A1
Mirzadeh, S1
Ferrier, MG; Radchenko, V1
Abbasi, S; Albooyeh, H; Alvandi, M; Farzipour, S; Shaghaghi, Z1
Allen, BJ2
Bertalan, T; Bruchertseifer, F; Holleran, T; Josefsson, A; Linz, T; Morgenstern, A; Sempkowski, M; Sofou, S; Zhu, C1
McDevitt, MR; Sgouros, G; Sofou, S1
Radchenko, V; Ramogida, CF; Robertson, AKH; Schaffer, P1
Apostolidis, C; Bruchertseifer, F; Kratochwil, C; Krolicki, L; Morgenstern, A; Sathekge, M1
Thiele, NA; Wilson, JJ1
Bednarz, B; Lee, D; Li, M; Schultz, MK1
Knapp, FFR; Radchenko, V; Schaffer, P1
Lougheed, T1
Apostolidis, C; Avila, LA; Dadachova, E; Hanzlik, RP; Iwamoto, T; Liu, K; Morgenstern, A; Sukthankar, P; Tomich, JM; Whitaker, SK1
Carrasquillo, JA; Cheung, NK; Larson, SM; Press, OW1
McDevitt, MR; Scheinberg, DA2
Apostolidis, C; Bruchertseifer, F; Morgenstern, A1
Fisher, DR; McNamara, BK; Soderquist, CZ1
Pozzi, OR; Zalutsky, MR1
Anderson, T; Atcher, R; Nayak, T; Norenberg, J1
Allen, BJ; Fan Liu, S; Melville, G1
Beattie, B; Carrasquillo, JA; Chattopadhyay, D; Henke, E; Jaggi, JS; Kappel, BJ; Larson, SM; Nagel, A; Scheinberg, DA; Schwartz, J; Seshan, SV; Sgouros, G; Xiao, J; Zanzonico, P1
Apostolidis, C; Geerlings, MW; Kaspersen, FM; van der Hout, R1
Imam, SK1
Bander, NH; Borchardt, P; Curcio, MJ; Frank, RK; Lai, LT; Ma, D; McDevitt, MR; Miederer, M; Pellegrini, V; Scheinberg, DA; Simon, J; Wu, K1

Reviews

12 review(s) available for actinium and Neoplasms

ArticleYear
Development of Targeted Alpha Therapy from Bench to Bedside.
    Journal of medical imaging and radiation sciences, 2019, Volume: 50, Issue:4S1

    Topics: Actinium; Alpha Particles; Bismuth; History, 20th Century; History, 21st Century; Humans; Neoplasms; Radioimmunotherapy; Radioisotopes; Radiotherapy

2019
Innovation, Impact, and Strategic Importance of Alpha-Emitting Radionuclides.
    Journal of medical imaging and radiation sciences, 2019, Volume: 50, Issue:4 Suppl 1

    Topics: Actinium; Alpha Particles; Humans; Neoplasms; Radioisotopes; Radiotherapy

2019
An Appendix of Radionuclides Used in Targeted Alpha Therapy.
    Journal of medical imaging and radiation sciences, 2019, Volume: 50, Issue:4 Suppl 1

    Topics: Actinium; Alpha Particles; Astatine; Bismuth; Humans; Neoplasms; Radioisotopes; Radiotherapy; Radium; Thorium

2019
Recent Achievements about Targeted Alpha Therapy-Based Targeting Vectors and Chelating Agents.
    Anti-cancer agents in medicinal chemistry, 2022, Volume: 22, Issue:8

    Topics: Actinium; Alpha Particles; Chelating Agents; Humans; Neoplasms; Radioimmunotherapy; Radium

2022
Targeted and Nontargeted α-Particle Therapies.
    Annual review of biomedical engineering, 2018, 06-04, Volume: 20

    Topics: Actinium; Alpha Particles; Animals; Cell Survival; Clinical Trials as Topic; Drug Carriers; Humans; Kinetics; Leukemia; Nanomedicine; Nanoparticles; Neoplasm Metastasis; Neoplasms; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Radium

2018
Development of
    Current radiopharmaceuticals, 2018, Volume: 11, Issue:3

    Topics: Actinium; Alpha Particles; Humans; Neoplasms; Radiochemistry; Radionuclide Generators; Radiopharmaceuticals

2018
An Overview of Targeted Alpha Therapy with
    Current radiopharmaceuticals, 2018, Volume: 11, Issue:3

    Topics: Actinium; Alpha Particles; Bismuth; Clinical Trials as Topic; Humans; Neoplasms; Radiochemistry; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals

2018
Radioimmunotherapy of human tumours.
    Nature reviews. Cancer, 2015, Volume: 15, Issue:6

    Topics: Actinium; Alpha Particles; Antibodies, Monoclonal; Clinical Trials as Topic; Hematologic Neoplasms; Humans; Molecular Targeted Therapy; Neoplasms; Radioimmunotherapy

2015
Actinium-225 in targeted alpha-particle therapeutic applications.
    Current radiopharmaceuticals, 2011, Volume: 4, Issue:4

    Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Clinical Trials as Topic; Humans; Liposomes; Models, Animal; Neoplasms; Radioimmunotherapy; Radiopharmaceuticals; Radiotherapy Dosage

2011
Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes.
    Current radiopharmaceuticals, 2012, Volume: 5, Issue:3

    Topics: Actinium; Aged; Aged, 80 and over; Alpha Particles; Animals; Bismuth; Clinical Trials as Topic; Humans; Mice; Mice, Transgenic; Middle Aged; Neoplasms; Radioisotopes; Radionuclide Generators; Radiopharmaceuticals

2012
Radioimmunotherapy with alpha-particle emitting radionuclides.
    The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2004, Volume: 48, Issue:4

    Topics: Actinium; Alpha Particles; Antibodies, Monoclonal; Astatine; Bismuth; Humans; Isotopes; Neoplasms; Practice Patterns, Physicians'; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Treatment Outcome

2004
Advancements in cancer therapy with alpha-emitters: a review.
    International journal of radiation oncology, biology, physics, 2001, Sep-01, Volume: 51, Issue:1

    Topics: Actinium; Alpha Particles; Antibodies, Monoclonal; Astatine; Beta Particles; Bismuth; Cell Death; Energy Transfer; Fermium; Humans; Immunoconjugates; Neoplasms; Radioisotopes; Radium; Relative Biological Effectiveness; Terbium

2001

Other Studies

16 other study(ies) available for actinium and Neoplasms

ArticleYear
Preclinical Evaluation of 225Ac-Labeled Single-Domain Antibody for the Treatment of HER2pos Cancer.
    Molecular cancer therapeutics, 2022, 12-02, Volume: 21, Issue:12

    Topics: Actinium; Animals; Cell Line, Tumor; Female; Humans; Mice; Neoplasms; Single-Domain Antibodies; Tissue Distribution; Trastuzumab

2022
A comparative evaluation of Ac225 vs Bi213 as therapeutic radioisotopes for targeted alpha therapy for cancer.
    Australasian physical & engineering sciences in medicine, 2017, Volume: 40, Issue:2

    Topics: Actinium; Alpha Particles; Bismuth; DNA Repair; Humans; Neoplasms; Organ Sparing Treatments; Radioisotopes; Radiopharmaceuticals

2017
Alpha-particle radiotherapy: For large solid tumors diffusion trumps targeting.
    Biomaterials, 2017, Volume: 130

    Topics: Actinium; Alpha Particles; Animals; Antibodies; Cell Death; Cell Line, Tumor; Cell Proliferation; Diffusion; Female; Histones; Humans; Hydrogen-Ion Concentration; Liposomes; Mice, Nude; Neoplasms; Phosphorylation; Spheroids, Cellular; Survival Analysis

2017
Actinium-225 for Targeted α Therapy: Coordination Chemistry and Current Chelation Approaches.
    Cancer biotherapy & radiopharmaceuticals, 2018, Volume: 33, Issue:8

    Topics: Actinium; Animals; Chelating Agents; Humans; Neoplasms; Radioisotopes; Radiopharmaceuticals

2018
Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
    Radiation research, 2018, Volume: 190, Issue:3

    Topics: Actinium; Alpha Particles; Beta Particles; Bismuth; Dose-Response Relationship, Radiation; Humans; Lead Radioisotopes; Lutetium; Neoplasm Metastasis; Neoplasms; Radioisotopes; Yttrium Radioisotopes

2018
The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications.
    Current radiopharmaceuticals, 2018, Volume: 11, Issue:3

    Topics: Actinium; Alpha Particles; Animals; Bismuth; Humans; Neoplasms; Radiochemistry; Radioisotopes; Radionuclide Generators; Radiopharmaceuticals

2018
Isotope once discarded as byproduct shows promise as cancer treatment.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2018, 12-10, Volume: 190, Issue:49

    Topics: Actinium; Alpha Particles; Chemical Industry; Compassionate Use Trials; Humans; Neoplasms; Palliative Care

2018
Branched amphiphilic peptide capsules: cellular uptake and retention of encapsulated solutes.
    Biochimica et biophysica acta, 2014, Volume: 1838, Issue:9

    Topics: Actinium; Capsules; Drug Delivery Systems; Humans; Lipid Bilayers; Liposomes; Nanospheres; Neoplasms; Particle Size; Peptides; Radioisotopes; Solutions

2014
Production of high-purity radium-223 from legacy actinium-beryllium neutron sources.
    Current radiopharmaceuticals, 2012, Volume: 5, Issue:3

    Topics: Actinium; Alpha Particles; Anion Exchange Resins; Beryllium; Humans; Neoplasms; Neutrons; Quality Control; Radioactivity; Radionuclide Generators; Radiopharmaceuticals; Radium

2012
A comparison of high- versus low-linear energy transfer somatostatin receptor targeted radionuclide therapy in vitro.
    Cancer biotherapy & radiopharmaceuticals, 2005, Volume: 20, Issue:1

    Topics: Actinium; Alpha Particles; Apoptosis; Beta Particles; Bismuth; Cell Line, Tumor; Cell Nucleus; Cell Survival; Dose-Response Relationship, Radiation; Energy Transfer; Enzyme-Linked Immunosorbent Assay; Humans; Ligands; Lutetium; Mitosis; Models, Statistical; Neoplasms; Octreotide; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptors, Somatostatin

2005
A theoretical model for the production of Ac-225 for cancer therapy by photon-induced transmutation of Ra-226.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2006, Volume: 64, Issue:9

    Topics: Actinium; Computer Simulation; Models, Theoretical; Neoplasms; Photons; Radionuclide Generators; Radium

2006
Addendum to: Basic immunology of antibody targeted radiotherapy: in regard to Wong (Int J Radiat Oncol Biol Phys 2006;66: S8-S14).
    International journal of radiation oncology, biology, physics, 2007, May-01, Volume: 68, Issue:1

    Topics: Actinium; Antibodies, Monoclonal; Antibody Specificity; Antigens, Neoplasm; Bismuth; Chondroitin Sulfate Proteoglycans; Humans; Membrane Proteins; Neoplasms; Radioimmunotherapy; Radioisotopes

2007
Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor.
    The Journal of clinical investigation, 2007, Volume: 117, Issue:9

    Topics: Actinium; Animals; Female; Histocompatibility Antigens Class I; Humans; Immunoglobulin G; Immunotherapy; Indium Radioisotopes; Injections, Intravenous; Iodine Radioisotopes; Mice; Neoplasms; Positron-Emission Tomography; Receptors, Fc; Time Factors

2007
The feasibility of 225Ac as a source of alpha-particles in radioimmunotherapy.
    Nuclear medicine communications, 1993, Volume: 14, Issue:2

    Topics: Actinium; Alpha Particles; Feasibility Studies; Humans; Neoplasms; Radioimmunotherapy

1993
Tumor therapy with targeted atomic nanogenerators.
    Science (New York, N.Y.), 2001, Nov-16, Volume: 294, Issue:5546

    Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Female; Half-Life; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Linear Energy Transfer; Lymphoma; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunotherapy; Survival Rate; Tumor Cells, Cultured

2001
Ac-225 and her daughters: the many faces of Shiva.
    Cell death and differentiation, 2002, Volume: 9, Issue:6

    Topics: Actinium; Alpha Particles; Animals; Beta Particles; Humans; Neoplasms; Radioimmunotherapy; Radioisotopes

2002